FENC vs PG · rev $44.6M vs P/E 25, rev $84.28B
Fennec Pharmaceuticals Inc (FENC) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Fennec Pharmaceuticals Inc (FENC) is a biotechnology company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported FENC revenue for 2025-12-31 was $44.6M. Net income was -$9.7M. Revenue was down 6.1% from 2024-12-31 to 2025-12-31. FENC currently screens at market cap $302.2M.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
FENC currently screens at market cap $302.2M. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the FENC and PG stock pages for the full models.
Not investment advice.